In addition, despite scarce literature about doxazosin and AD biomarkers, a recent study showed that doxazosin prevented Akt reduction, avoiding tau phosphorylation in an in vitro model of organotypic hippocampal cultures exposed to Aß [18]. Here, MAPT is linked to Alzheimer disease.